Hansen Medical Announces FDA Clearance For CoHesionTM Module
Jul 4th 2008Drug InformationCardiovascular
Hansen Medical, Inc. (NASDAQ: HNSN), a developer of robotic technology for accurate 3D control of catheter movement during cardiac procedures, has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the CoHesion? 3D Visualization Module for use in complex electrophysiology (EP) mapping procedures.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
